Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Market-Moving News for July 13th

Benzinga Newsdesk Jul 13, 2026 3 months ago

MoversTrading Ideas

QTTB: 82% | Q32 Bio shares are trading higher after the company it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday, July 13, 2026. AGEN: 36% | Agenus To Raise $85M To

QTTB: 82% | Q32 Bio shares are trading higher after the company it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday, July 13, 2026.

AGEN: 36% | Agenus To Raise $85M To Fund Colon Cancer Drug Trial, Financing Could Reach $340M If Warrants Are Exercised

SHOP: 2% | Jefferies Upgrades Shopify to Buy, Raises Price Target to $160

Read the original